Join our community of smart investors

Shawbrook increases profits despite asset finance stumble

The challenger bank increased profits solidly despite taking a provision for asset finance loan impairments
March 8, 2017

Shawbrook (SHAW) has rejected a revised takeover bid worth 330p a share from a consortium that includes its largest shareholder, Pollen Street Capital. That drama rather overshadowed what was a solid set of 2016 trading figures. The challenger bank grew its loan book by more than a fifth to £4.1bn. Increasing income also helped bring down the cost-to-income ratio to 45.1 per cent (from 48.3 per cent in 2015).

IC TIP: Hold at 318.2p

Property finance continued to drive growth, with £1bn in new loans written. Unsurprisingly, buy-to-let applications during the first quarter surged ahead of the stamp duty changes. Anticipating a softer market in future, management diversified its client base by launching development finance products aimed at smaller housebuilders.

The business finance division had a more troubled year. Discovering some asset finance loans had been written outside of the bank's lending criteria forced it to take a £11.2m impairment charge. Business clients also deferred investments, meaning new asset finance loans were down more than a quarter.

However, working capital loans were much stronger, with balances growing 38 per cent to £253m. The consumer finance division agreed distribution deals with RAC and Saga (SAGA), which should help build on the £500m in year-end balances.

Analysts at Numis expect net tangible assets of 165.3p a share at December 2017.

SHAWBROOK (SHAW)

ORD PRICE:318.2pMARKET VALUE:£797m
TOUCH:318.2-318.9p12-MONTH HIGH:323pLOW: 117p
DIVIDEND YIELD:0.8%PE RATIO:12
NET ASSET VALUE:175pLEVERAGE:12.2

Year to 31 DecTotal operating income (m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
2012*24.7-7.1-7.0nil
2013*60.116.110.0nil
2014*11245.321.0nil
201516770.124.1nil
201621088.225.92.7
% change+26+26+7-

Ex-div: 1 Jun

Payment: 30 Jun

*Pre-IPO figures